IBM, Partners Claim 2026 Quantum Advantage With 120-Qubit Results and $1 Trillion Market Bet
Updated
Updated · Newsweek · Aug 19
IBM, Partners Claim 2026 Quantum Advantage With 120-Qubit Results and $1 Trillion Market Bet
3 articles · Updated · Newsweek · Aug 19
Summary
IBM and its partners say 2026 is the year quantum computing began delivering commercial-grade results, with multiple public tests aimed at proving “quantum advantage” on real problems rather than lab benchmarks.
Q-CTRL reported one of the clearest gains: an IBM 120-qubit processor solved an electron-transport problem in 2 minutes 46 seconds, versus as long as 160 hours for the best classical software on rented clusters.
Three more claims landed in late July, shifting the debate from raw speed to verifiable answers: a University of Chicago team cut errors 10-fold in a 15-minute run, while Qedma and Algorithmiq posted results classical methods have struggled to match.
Cleveland Clinic said hybrid quantum-classical workflows pushed molecular simulation from 10 atoms in October 2024 to a 12,600-atom protein system by May 2026, highlighting drug discovery and fusion chemistry as early use cases.
IBM has tied those advances to a larger business push, forecasting measurable revenue impact by 2028 or 2029, targeting a 2029 error-corrected Starling system, and backing the effort with a $1 billion CHIPS Act award.
Can IBM's massive ten-billion-dollar gamble on near-term quantum advantage actually pay off before fully fault-tolerant machines arrive in 2029?
With IBM's recent 2026 breakthroughs, have quantum computers finally crossed the threshold to render our most powerful classical supercomputers obsolete?
As hybrid quantum workflows successfully simulate massive proteins, how long until AI-driven classical algorithms strike back to reclaim their crown?